Treatment of Hypertension in Children
动脉导管未闭介入封堵术后的急性并发症的危险因素分析及治疗规范

Advances in Clinical Medicine 临床医学进展, 2021, 11(5), 2155-2160Published Online May 2021 in Hans. /journal/acmhttps:///10.12677/acm.2021.115308动脉导管未闭介入封堵术后的急性并发症的危险因素分析及治疗规范孙仕涵,李谧重庆医科大学附属儿童医院,重庆收稿日期:2021年4月17日;录用日期:2021年5月2日;发布日期:2021年5月19日摘要动脉导管未闭是一种常见的先天性心脏病,尤其在早产儿当中发病率较高。
由于动脉导管未闭左向右分流的血流动力学特点,左心系统血流量持续增多,导致肺动脉压力增高,管壁重构,最终形成不可逆的梗阻性肺动脉高压,从而错失手术时机,因此应尽早治疗动脉导管未闭。
目前介入封堵术发展迅速,已成为动脉导管未闭的首选治疗方式,但其仍存在一定并发症的发生。
本文从介入封堵术治疗动脉导管未闭术后急性并发症的危险因素分析,从而讨论其防治措施及治疗规范。
关键词动脉导管未闭,并发症,介入治疗,危险因素Risk Factors and Treatment Criteria forAcute Complications after PatentDuctus Arteriosus OcclusionShihan Sun, Mi LiAffiliated Children’s Hospital of Chongqing Medical University, ChongqingReceived: Apr. 17th, 2021; accepted: May 2nd, 2021; published: May 19th, 2021AbstractPatent ductus arteriosus is a common congenital heart disease, especially in premature infants.孙仕涵,李谧Due to the hemodynamic characteristics of the left-to-right shunt of patent ductus arteriosus, the blood flow of the left cardiac system continues to increase, resulting in increased pulmonary ar-tery pressure, wall remodeling, and finally irreversible obstructive pulmonary hypertension, thus missing the opportunity for operation. Therefore, patent ductus arteriosus should be treated as soon as possible. At present, interventional occlusion is developing rapidly, and it has become the first choice for the treatment of patent ductus arteriosus, but it still has a certain complications. In this paper, the risk factors of acute complications after transcatheter closure of patent ductus ar-teriosus were analyzed, and the preventive measures and treatment criteria were discussed.KeywordsPatent Ductus Arteriosus, Complications, Interventional Therapy, Risk Factors Array Copyright © 2021 by author(s) and Hans Publishers Inc.This work is licensed under the Creative Commons Attribution International License (CC BY 4.0)./licenses/by/4.0/1. 引言动脉导管未闭发生率约占先天性心脏病的10%~15% [1],尤其在早产儿中发生率较高,约55%~75%[2],而诊疗不及时常可因肺小动脉阻力增高,管壁增厚出现梗阻性肺动脉高压,临床上表现为差异性青紫,即艾森曼格综合征等从而错失手术时机。
肺动脉高压儿童who分级标准

肺动脉高压儿童who分级标准Pulmonary arterial hypertension (PAH) in children refers to increased pressure in the arteries that carry blood from the heart to the lungs. This condition can be classified using the World Health Organization (WHO) functional classification system. The WHO classification system is based on the impact of the disease on a child's ability to perform daily activities and ranges from Class I (mild symptoms with no limitation) to Class IV (severe symptoms with inability to carry out any physical activity without symptoms).肺动脉高压(PAH)是指儿童体内的动脉压力增高,这些动脉将血液从心脏输送至肺部。
该疾病可以使用世界卫生组织(WHO)功能分类系统进行分类。
WHO分类系统依据疾病对儿童日常活动表现的影响,分为I级(轻微症状无限制)到IV级(严重症状导致无法进行任何体力活动无症状)。
Early diagnosis and appropriate classification of PAH in children are crucial for effective management and treatment. Children with PAH may present with symptoms such as shortness of breath, fatigue, chest pain, dizziness, and fainting. These symptoms can significantlyimpact their quality of life and require timely intervention to prevent disease progression and complications.对儿童进行早期诊断并进行恰当的分类对于有效管理和治疗PAH至关重要。
突发性耳聋中西医治疗进展

National the
high
high
blood pressure
on
program
working
group. of 11
441—447.
fourth report
the
diagnosis,evaluation and and
treatment
杨年红.胡虞志。黄艳.我国11城市儿童单纯性肥胖症调查及 影响因素分析[J].同济医科大学学报,1999,28(5):
H.Prevalence of
Julius
S.Nesbitt
SD,Egan with
an
BM,et
a1.Feasibility of
treating N
adolescents in
porto,portugal口].Rev
Port Cardiol。2005,24
prehypertension En91
4 Urbina E,Alpert B,Flynn monitoring standard heart youth young in children and 13 pressure for 14
Dis。1999.33(2):253—260. Capdevila
OS,Kheirandish—Gozal
blood pressure
D,et in
a1.Relationship
between Kidney
EJ].Pediatr
Nephrol,2000,14(4):332—341.
birthweight and
childhood[J].AM J
3范华,张钦风,吴多文.儿童高血压诊断标准的研究进展[J]. 中华高血压杂志,2007,15(8):627—629.
【doc】安氏Ⅲ类错[牙合]早期矫治的方法
![【doc】安氏Ⅲ类错[牙合]早期矫治的方法](https://img.taocdn.com/s3/m/35636cde6037ee06eff9aef8941ea76e58fa4ad5.png)
安氏Ⅲ类错[牙合]早期矫治的方法第1期华夏医学第23卷[5]NAWORTTS,STAESSENJATHUSL,ete1.Should pulsepressurbecomepartoftheFraminghamriskscoreD].HumanHypertens,2004,18(4):279—286.[6]郭艺芳,张保敏,胡大一.时间心脏病学研究现状[J].中华心血管病杂志,2004,32(6):557—560.[7]施仲伟.顽固性高血压的降压治疗[J].心血管病学进展,2007,28(5):665—668.[8]赵鑫.高龄老年高血压的临床研究进展口].L-血管病学进展,2009,30(1):50—53.[9]GUEYFLERF,BULPITTC,BOISSELJP,eta1.Anti—hypertensivedrugsinverypeople:asubgroupmeta—anal—ysisofrandomizedcotrolledtrials.INDANAGroup[J].Lancet,1999,353(9155):793—796.[1O]MATTILAK,HAA VISTOM,RAJALAS,eta1.Blood pressureandfiveyearsurvivalintheveryold[J].BrMedJ,1988,296(6626):887—889.[11]RASTASS,PIRTTILAT,VIRAMOP,eta1.Associa—tionbetweenbloodpressureandsurvivalover9yearsin安氏Ⅲ类错殆早期矫治的方法陈玉梅综述,钱成明审校(桂林市妇女儿童医院,广西桂林541001)ageneralpopulationaged85andolderD].JAmGeriatrSoc,2006,54(6):912—9l8.[12]BECK[TTNS,PETERSR,FLETCHERAE,eta1. Treatmentofhypertensioninpatients80yearsofageorolder[J1.NEnglJMed,2008,358(18):1887—1898.[13]沈玲红,王长谦,王彬虎.钙通道阻滞荆的血液流变学效应[J].心血管病学进展,2001,22(6):330—333.[14]赵水平,胡大一.血管病诊疗指南解读[M].2版.北京:人民卫生出版社,2007:231—239.[15]刘国仗,卫文君.高血压诊断和治疗研究进展口].中华心血管病杂志,2003,31(12):884—888.[16]CHOBANIANAV,BAKRISGL,BLACKHR,eta1. Seventhreportofthejointnationalcommitteeonpre—vention,detection,evaluation,andtreatmentofhighbloodpressure[J].Hypertension,2003,42(6):1206—1252.[收稿日期:2009—12—03][责任编辑:王慧瑾]关键词:安氏I类错胎;矫治器;早期矫治中图分类号:R783文献标识码:A文章编号:1008—2409(2010)01—0108—03 安氏Ⅲ类错黯是临床较为常见的错牙台畸形.据中华口腔医学会2000年的调查表明,中国人群安氏Ⅲ类错黯乳牙列发病率为14.94,替牙列为9.65,恒牙列14.98[1].它严重影响儿童颅面部正常生长发育,并随着个体的生长畸形有逐渐加重的趋势[2≈].由于安氏nl类错殆对患者的口腔功能,颜面美观以及心理健康有较严重的影响,因此早期矫治尤为重要[4].早期矫治有利于患者的生长潜力,促进发育不足的上颌向前生长,抑制下颌骨的过度生长,减轻颌骨的畸形度Is],并对儿童的上下颌骨,牙齿以及口周肌肉系统的正常发育有着较为重要的作用L6J.值得注意的是替牙期矫治的时机十分重要,应最大限度地使上下颌骨发生有利的改变[1].目前国际上矫治时机还没有一个被广泛接受的标准[7],最早开始于乳牙期,Saadia等[8]也认为Ⅲ类错黯只要患者能够配合便可以开始矫治.目前临床上早期矫治的方法多种多】O8?样],有传统的殆垫式活动矫治器,导弓式殆垫矫治器,前方牵引矫治器,2×4技术固定矫治器, FrankelⅢ矫治器,改良式殆垫矫治器等.现就安氏Ⅲ类错狳早期矫治的方法综述如下.1传统的牙合垫式活动矫治器早在1954年黄金芳教授在中华口腔科杂志上发表的《早期前牙反胎——急待解放的生长发育》一文[1引,提出用聒垫双曲舌簧矫正前牙反黯,把早期矫治反殆称为'解放前颌骨'能使上颌的增长发育得到解放.儿童替牙期是矫治前牙反黯的关键期[1,如果不能及时地解除反殆,畸形可能发展严重,给日后的治疗增加难度.50年来乳牙期,替牙期,恒牙期的牙源性前牙反殆至今临床上仍以经典的黯垫双曲舌簧矫治器来矫正L】"..,但由于它的作用是改变上颌切牙的倾斜度,对于骨骼的影响有限,因此它对于乳牙第1期陈玉梅:安氏Ⅲ类错将早期矫治的方法第23卷期牙源性前牙反黯的治疗效果较好,而对于乳牙期伴一定程度骨骼畸形的m类错黯患者很难建立稳定的咬合关系.另外它只作用于上颌,不能够控制下颌,对反殆的凹陷面型改观不明显u,而且上前牙易出现散在小间隙,仅适用于下颌前突不明显的前牙反黯.2导弓式活动矫治器导弓式活动矫治器是一种功能与机械相结合的矫治器,具有颌间牵引及颏兜功能[1¨.在儿童或青少年时期,人体及颌骨的生长发育较快,如果在这个时期过长地戴用矫治器对颌骨的生长发育有一定限制作用].因此在设计矫治器时必须考虑顺应牙弓的正常生长发育,尽力缩短戴矫治器的时间,防止因矫治作用不当影响颌骨生长发育L2.导弓式活动矫治器是利用FKO功能矫治器的主要装置诱导弓并结合上颌胎垫矫治器的特点改制而成],通过诱导弓使下颌后退,很快解除反殆,矫治时间相对变短,但适应证较局限,而且导弓弯制较困难,在取对刃黯记录时可能因患儿年龄小,与医生配合不协调L1.3前方牵引矫治器早在100年前,前方牵引矫治器就用于矫治安氏Ⅲ类错黯,尤其是对于处在生长发育期的患者L7].近年来一些文献报道了应用前方牵引器后,骨骼,牙齿及软组织发生显着的变化[22-23].包括上颌骨向前上移动即发生逆时针旋转,下颌骨向后向下旋转;上切牙唇倾下切牙舌向移动[1引.文献认为前方牵引器应在替牙早期使用,以促进骨骼的改变而使牙性代偿相对减少.Miyajima等[2t]发现,生长发育早期上颌后缩,在以后的生长发育阶段,上颌骨对颅骨的关系保持相对稳定.因此早期前方牵弓l可促进上颌骨的生长发育,对由于上颌骨后缩导致的安氏Ⅲ类错黯是一种有效的方法F.引.但对下颌向前生长没有抑制作用[5],而且依赖患者的合作程度.42×4技术矫治器2×4技术是通过改变切牙唇倾度和下颌骨的旋转矫治前牙反黯Ⅱ.引.随着上切牙唇倾度的改变"A"点前移并促进上颌骨生长发育[2.它是一种简单而有效的方法,在治疗阶段患者的合作程度比戴用前方牵引器更易于控制,由于患者合作的可控制性,因此得到良好的治疗效果[2.替牙期不便粘着全口固定矫治器,使用2×4技术矫治前牙反j恰使矫治不失时机同时又能发挥固定矫治器优势,该技术不仅可唇向移动上切牙,还可以对其进行垂直方向上的调整[1引, 但由于固定矫治器不利于保持口腔卫生,易导致菌斑滞留引起牙釉质脱矿[2引.5Frankel功能娇治器6O年代德国正畸学者Frankel改良设计的功能矫治器,近3O年来已广泛应用,我国对Frankel的应用也逐渐开展.它是通过改变影响下颌位置与功能的肌肉,把力传至牙齿和骨骼而起到矫治作用.对Ⅲ类错黯关系的颌间作用是引起上颌牙齿近中移动,下颌牙齿则向远中移动.戴用Frankel功能矫治器可使上颌牙弓宽度增加,下颌牙弓长度减少,使前牙反殆得到解除,同时纠正下颌不良的生长趋势,建立新的肌肉平衡[1'.u,但矫治器体积较大,患儿不易接受.6改良式殆垫矫治器改良式黯垫矫治器是在传统的殆垫矫治器上通过增加下颌双曲唇弓,控制下颌骨向前生长,是一种功能与机械相结合的活动矫治器[1引.舌簧为机械力, 双曲唇弓具有颌间牵引及颏兜功能,以协调上下颌骨间大小,形态,位置,利于上下颌骨的生长趋向正常[3.通过生长改型,利用患者的生长潜力,促进发育不足的上颌向前生长,抑制下颌骨的过度生长,治疗轻度的颌骨畸形,并减轻颌骨的畸形度L5].并且还可以调节下颌双曲唇弓内收下前牙,有关闭下前牙间隙的作用[3引,避免了以往戴用颏兜及颌间牵引等繁琐程序,缩短疗程,而且矫治器制作较简单,使用方便,口腔卫生易保持,患儿易配合,对面型改善较好[11,3S-343.综上所述,儿童正处于生长发育快速期,骨骼受力后易发生改建,AngleⅢ类错黯早期矫治非常重要.改良式黯垫矫治器同时具有机械及肌能矫治的双重作用,可以同时改善上下颌骨的位置关系而且疗程短,见效快.该方法减少了患者的复诊次数,缩短了治疗时间,降低了治疗费用,下颌后退效果更明显,使牙,颌,面关系更协调,从而获得较好的社会效益及经济效益.参考文献:[1]傅民魁.口腔正畸专科教程EM].北京:人民卫生出版1O9?第1期华夏医学第23卷社,2007,340—408.[2]KAPURA,CHAWLAHS,UTREJAA.EarlyClassI occlusaltendencyinchildrenanditsselectivemanage--ment口].JIndianSocPedodPreyDent,2008,26(3):1O7一l13.[3]MOONYM,AHNSJ,CHANGYI.CephalometricPre—dictorsoflong-termstabilityintheearlytreatmentof ClassImalocclusion[33.AngleOrthod,2005,75(5): 747—753.[4]傅民魁.口腔正畸学[M].4版.北京:人民卫生出版社, 2003:210—220.[5]周彦恒.安氏ii类错殆畸形的诊断和治疗[J].口腔正畸学,2000,7(1):40—43.[6]徐鸿骏,黄良平,王玉刚.乳前牙反骀几种矫治方法和适应时间的临床对比[J].实用口腔医学杂志,2005,21(3): 419.[7]KANNOZ,KIMY,SOMAK.Earlycorrectionofade—velopingskeletalClassImalocclusion[J].AngleOr—thod,2007,77(3):549—556.[8]SAADIAM,TORRESE.Sagittalchangesaftermaxil—laryprotractionwithexpansioninClassIpatientsinthe primary,mixed,andlatemixeddentitions:alongitudi- nalretrospectivestudy[J].AmJOrthodDentofaeialOr—thop,2000,117:669-680.[9]姚森译.口腔正畸矫治器彩色图谱一科学选择和使用矫治器的秘诀[M].西安:世界图书出版公司,2003:234—249.[1o]邢牧.替牙期黯垫式活动矫正器矫治反验29例[J].徐州医学院,2004,24(6):593—594.[11]孔凡芸,王春玲.改良式导弓矫治乳牙反黯[J].山东医药,2003,43(35):14—16.[12]贾漪林,王海岚,王以玲.前方牵引对于乳牙期骨性iI类错黔牙颌结构的影响[J].口腔正畸学,2003,i0(4):156~158.[13]袁虹."2X4"矫治技术的力学特点及临床应用[J].口腔正畸学,1999,6(1):33—34.[14]陈世稳.Frankel功能矫治器研究进展[J].医学文选, 2000,19(5):774—775.[15]林珠.口腔正畸治疗学[M].西安:世界图书出版公司,l998:399—400.[16]黄金芳.早期前牙反牙台一急待解放的生长发育口].口腔正畸学,2002,9(4):145—150.[17]陈析华.儿童骨性I类错雅早期颅面形态特征[J].口腔正畸学,2002,9(3):135—136.[18]沈真祥.口腔正畸临床诊断[M].北京:科学技术文献出版社,2003:200—212.11O?[19]VIRKKULAT,KANTOMAAT,JULKUJ,eta1.Long- termsoft—tissueresponsetoorthodontictreatmentwith earlycervicalheadgear-arandomizedstudy[J].AmJ OrthodDentofacialOrthop,2009,135(5):586—596.[2o]孙福绵,郭智博.活动矫治器在正畸治疗中应用体会[J].中华中西医学杂志,2006,4(12):30—31.[21]林珠,段银钟,丁寅,等.口腔正畸治疗学[M].北京:人民卫生出版社,2002:6-107.[22]GODTA,ZEYHERC,SCHATZ—MAIERD,eta1.Early treatmenttocorrectClassIrelationswithorwithout facemasks[J].AngleOrthod,2008,78(1):44—49.[23]王秀婧,阎燕.单纯前方牵引矫治器矫治骨性I类错黯的软硬组织的改变[J].中华口腔正畸学杂志,2009,16 (4):211-214.[24]MlYAJIMAK,MCNAMARAJA,SANAM,eta1.An estimationofcraniofacialgrowthintheuntreatedclass皿femaleswithanteriorcrossbites[J].AmJOrthod DentofacialOrthop,1997,112:425—434.[25]谷岩.替牙期安氏1类错黯治疗方法选择的初步研究[J].口腔正畸学,2002,9(4):154—158.[26]YANGU,ABMRABIE.Treatmenteffectsofsimple fixedapplianceandreverseheadgearincorrectionofan—teriorcrossbites[J].AmJOrthodDentofacOrthop,2000,1l7:691-699.[27]徐璐璐,段银钟,陈莉莉.2×4技术配合I类牵引矫治替牙期轻度骨性反黯[J].临床口腔医学杂志,2003,19 (7):432—434.[28]陈玉梅,王传涛,李大建,等.固定矫治中牙釉质脱矿的防治观察[J].广西预防医学,2004,10(1):37—38.[29]陈淑玲,闫红窈,张杰.采用FR—I型矫治器治疗安氏Ⅱ类错黯[J].口腔正畸学,1997,4(2):77.[3O]BACCETTIT,REYESBC,MCNAMARAJAJR. CraniofacialchangesinClassImalocclusionasrelated toskeletalanddentalaturation[J].AmJOrthod DentofacOrthop,2007,132:171-183.[31]陈世稳,周嫣,黄敏方,等.颜面不对称畸形9例正畸矫治分析[J].广西医学,2004,26(1O):1501?1502.[32]彭友俭,高嘉泽.口腔正畸早期治疗学[M].武汉:湖北科技出版社,2001:67—81.[33]江笑露,郭键力,李传宇.导弓式活动矫治器矫治前牙反骀5O例临床观察[J].吉林医学,1998,19(3):169.[34]李剑峰.早期前牙反黔应用胎垫与诱导唇弓联合矫治的临床观察[J].锦州医学院,2006,27(4):76.[收稿日期:2010一O1—06][责任编辑:王慧瑾]。
儿科指南目录(英文)

1.European Consensus Guidelines on the Management of Respiratory DistressSyndrome - 2016 Update.EAPM欧洲指南共识:呼吸窘迫综合征的管理(2016更新版)2.Management of undescended testes: European Association of Urology/EuropeanSociety for Paediatric Urology Guidelines. EAU/ESPU指南:隐睾症的管理(2016)3.Recommendations for Prevention and control of influenza in children,2016-2017.AAP儿童流感的预防与控制建议(2016~2017)4.ESPGHAN-NASPGHAN Guidelines for the Evaluation and Treatment ofGastrointestinal and Nutritional Complications in Children with EsophagealAtresia- Tracheoesophageal Fistula. SPGHAN/NASPGHAN指南:儿童食管闭锁,气管食管瘘胃肠道和营养并发症的评估和治疗(2016)5.Prevention of food and airway allergy: consensus of the Italian Society ofPreventive and Social Paediatrics, the Italian Society of Paediatric Allergy andImmunology, and Italian Society of Pediatrics.意大利儿童食物和呼吸道过敏预防共识(2016)6.Official American Thoracic Society Clinical Practice Guidelines DiagnosticEvaluation of Infants with Recurrent or Persistent Wheezing. ATS临床实践指南:婴儿复发性或持续性喘息的诊断评估(2016)7.ACR Appropriateness Criteria Fever Without Source or Unknown Origin-Child. ACR适宜性标准:儿童无源性或不明原因发热(2016)8.2016 European Society of Hypertension guidelines for the management of highblood pressure in children and adolescents. ESH指南:儿童青少年高血压的管理(2016)9.2016 European Society of Hypertension guidelines for the management of highblood pressure in children and adolescents. NASPGHAN/ESPGHAN联合建议:婴幼儿胆汁淤积性黄疸的评估指南(2016)10.Recommendations for neonatologist performed echocardiography in EuropeConsensus Statement endorsed by European Society for Paediatric Research(ESPR) and European Society for Neonatology (ESN). ESPR/ESN共识声明:新生儿超声心动图检查建议(2016)11.Clinical recommendations for pain, sedation, withdrawal and delirium assessmentin critically ill infants and children an ESPNIC position statement for healthcare professionals. ESPNIC立场声明:危重婴幼儿和儿童疼痛,镇静,戒断和精神状态评估建议(2016)12.International Pediatric Otolaryngology Group (IPOG) consensus recommendations:Routine peri-operative pediatric tracheotomy care. IPOG共识建议:常规术前小儿气管切开管理(2016)13.Prevention of Vitamin K deficiency bleeding in newborn infants a position paperby the ESPGHAN Committee on Nutrition. ESPGHAN意见书:预防新生儿维生素K 缺乏性出血(2016)14.Daily iron supplementation in infants and children Guideline. WHO指南:婴儿和儿童每日铁补充(2016)15.Guideline for the Treatment of Breakthrough and the Prevention of RefractoryChemotherapy-Induced Nausea and Vomiting in Children With Cancer. POGO指南:儿童肿瘤患者顽固性化疗引起的恶心呕吐突破性治疗和预防(2016)16.Experts' recommendations for the management of cardiogenic shock in children.儿童心源性休克管理专家建议(2016)17.NICE:Intravenous fluid therapy in children and young people in hospital. NICE指南:住院儿童和青年人静脉补液治疗18.Recommendations for the prevention and treatment of haemolytic disease of thefoetus and newborn.胎儿和新生儿溶血性疾病的预防和治疗建议19.Recommendations from the Pediatric Endocrine Society for Evaluation andManagement of Persistent Hypoglycemia in Neonates, Infants, and Children. PES 推荐建议:新生儿,婴儿以及儿童持续性低血糖的评估和管理20.CSACI position statement: systemic effect of inhaled corticosteroids on adrenalsuppression in the management of pediatric asthma. CSACI共识声明:小儿哮喘管理吸入糖皮质激素对肾上腺皮质抑制的全身毒性作用21.NICE clinical guideline:Bronchiolitis in children. NICE临床指南:儿童毛细支气管炎22.Practice Guideline: Epistaxis in Children.儿童鼻出血实践指南23.Summary of recommendations for the management of infantile seizures: TaskForce Report for the ILAE Commission of Pediatrics. ILAE儿科专家组报告:小儿癫痫的管理建议(摘要)24.Finnish guidelines for the treatment of laryngitis, wheezing bronchitis andbronchiolitis in children.芬兰儿童喉炎、哮喘支气管炎和毛细支气管炎的治疗指南25.KHA-CARI guideline: Diagnosis and treatment of urinary tract infection in children.KHA-CARI指南:儿童尿路感染的诊断和治疗26.Recommendations for transfusion therapy in neonatology.新生儿输血治疗建议27.Managing possible serious bacterial infection in young infants when referral is notfeasible. WHO指南:婴儿潜在严重细菌感染的管理28.Practice parameter for the diagnosis and management of primaryimmunodeficiency.原发性免疫缺陷的诊断和管理指南29.Finnish guidelines for the treatment of community-acquired pneumonia andpertussis in children. FMSD指南:芬兰儿童社区获得性肺炎和百日咳的治疗mittee Opinion No. 644: The Apgar Score. ACOG/AAP委员会意见:阿普伽新生儿评分(No.644)31.Global Consensus Recommendations on Prevention and Management ofNutritional Rickets.全球共识建议:营养性佝偻病的预防和管理(2016)32.The prevention of early-onset neonatal group B streptococcus infection: NewZealand Consensus Guidelines 2014.新西兰共识指南:早发型新生儿B组链球菌感染的预防33.Queensland Clinical Guideline: Hypoxic-ischaemic encephalopathy (HIE). 昆士兰临床指南:缺血缺氧性脑病(HIE)(2016)34.ASCIA guidelines for prevention of anaphylaxis in schools, pre-schools andchildcare: 2015 update. ASCIA指南:学龄,学龄前儿童过敏性反应的预防(更新版)35.Guidelines for Feeding Very Low Birth Weight Infants. 极低出生体重婴儿喂养指南。
不同年龄段血压计算标准

不同年龄段血压计算标准English Answer:The definition of hypertension in adults (18 years and older) is a systolic blood pressure (SBP) greater than or equal to 130 mm Hg and/or a diastolic blood pressure (DBP) greater than or equal to 80 mm Hg.However, the blood pressure ranges for children and adolescents are different from those for adults. The American Academy of Pediatrics (AAP) has established specific guidelines for the diagnosis of hypertension in children and adolescents.For children and adolescents aged 1 to 18 years, hypertension is defined as an SBP that is greater than or equal to the 95th percentile for age, sex, and height on three separate occasions. The DBP is not used to diagnose hypertension in children and adolescents.The AAP has developed a table that lists the blood pressure percentiles for children and adolescents aged 1 to 18 years. The table is based on data from the National Health and Nutrition Examination Survey (NHANES).To use the table, find the child's age, sex, and height. Then, find the corresponding SBP percentile. If the child's SBP is greater than or equal to the 95th percentile onthree separate occasions, the child is considered to have hypertension.For example, a 10-year-old boy who is 4 feet 6 inchestall has an SBP of 125 mm Hg. According to the AAP table,the 95th percentile SBP for a 10-year-old boy who is 4 feet 6 inches tall is 122 mm Hg. Therefore, this boy has hypertension.It is important to note that hypertension in children and adolescents is a serious condition. It can lead to a number of health problems, including heart disease, stroke, and kidney disease. If your child is diagnosed with hypertension, it is important to follow your doctor'srecommendations for treatment.Chinese Answer:不同年龄段的血压计算标准有以下不同:对于18岁及以上的成年人,高血压的定义是收缩压(SBP)大于或等于130毫米汞柱和/或舒张压(DBP)大于或等于80毫米汞柱。
注射用牛肺表面活性剂不同给药方式在新生儿胎粪吸入综合征中的应用

注射用牛肺表面活性剂不同给药方式在新生儿胎粪吸入综合征中的应用张莉1,黄玉焕2,周曼丽2南阳市第一人民医院新生儿重症医学科1、新生儿科2,河南南阳473000【摘要】目的探讨注射用牛肺表面活性剂不同给药方式在新生儿胎粪吸入综合征(MAS)中的应用效果。
方法回顾性分析2021年3月至2023年3月南阳市第一人民医院收治的120例MAS 患儿的临床资料,根据给药方式不同分为A 组和B 组各60例。
A 组患儿采用肺泡灌洗+气管内滴入给药,B 组患儿采用气管内滴入给药,连续治疗48h 。
比较两组患儿的临床疗效,以及治疗前后的血气指标[氧分压(PaO 2)、二氧化碳分压(PaCO 2)、氧指数(OI)]、肺动脉收缩压(SPAP)、凝血纤溶指标[D -二聚体(D-D)、纤溶酶原激活抑制剂-1(PAI -1)/组织型纤溶酶原激活物(t-PA)、血小板活化因子(PAF)]、炎症因子[肿瘤坏死因子-α(TNF -α)、降钙素原(PCT)、白细胞介素-5(IL -5)、白细胞介素-13(IL -13)]水平,同时比较两组患者的康复相关指标和并发症发生情况。
结果A 组患儿的治疗总有效率为91.67%,明显高于B 组的76.67%,差异有统计学意义(P <0.05);治疗后,A 组患儿的PaO 2为(60.65±6.33)mmHg ,明显高于B 组的(56.12±5.93)mmHg ,PaCO 2、OI 、SPAP 分别为(42.36±4.02)mmHg 、13.10±1.12、(26.14±2.67)mmHg ,明显低于B 组的(45.66±4.33)mmHg 、(15.66±1.53)、(29.46±3.11)mmHg ,差异均有统计学意义(P <0.05);治疗后,A 组患儿的血浆D-D 、PAI -1/t-PA 、PAF 含量分别为(1.35±0.38)mg/L 、3.52±0.78、(404.55±78.78)×109/L ,明显高于B 组的(1.00±0.31)mg/L 、2.64±0.71、(340.59±65.33)×109/L ,差异均有统计学意义(P <0.05);治疗后,A 组患儿的血清TNF -α、PCT 、IL -5、IL -13含量分别为(11.11±1.01)ng/L 、(0.78±0.23)ng/mL 、(0.90±0.34)pg/mL 、(1.15±0.66)pg/mL ,明显低于B 组的(13.75±1.63)ng/L 、(1.46±0.34)ng/mL 、(1.50±0.40)pg/mL 、(1.63±0.94)pg/mL ,差异均有统计学意义(P <0.05);A 组患儿的发绀、吸气性三凹征消失时间及氧疗时间、住院时间、机械通气时间明显短于B 组,差异均有统计学意义(P <0.05);A 组患者的并发症总发生率为1.67%,明显低于B 组的15.00%,差异有统计学意义(P <0.05)。
职业健康监护技术与诊断处理再认识(Occupational health monitoring and diagnosis treatment)

职业健康监护技术与诊断处理再认识(Occupational health monitoring and diagnosis treatment)Occupational health examination and occupational disease diagnosis standard and the disposition of common problems1. Who saves () B on the occupational health checklistA. laborerB. EmployerC. Inspection organizationD. Health administration2. The occupational-disease-diagnosis institutions shall organize the diagnosis (C) within the time of acceptanceA, 10 daysB, 20 daysC, 30 daysD, 40 days3. Which of the following is not the legal basis for the diagnosis of occupational diseases () BA, the law of the People's Republic of China on occupationaldiseasesB. Measures for the management of occupational health careC. National occupational health standardsD. The terminology of occupational diseases4. Which of the following does not belong to the purpose of occupational health examination () AA. Determine whether the laborer is fit to continue with the workB. Understand the health status of workers when they leave the postC. Responsibility for health damageD. determine whether workers have occupational health damage5. The purpose of pre-job occupational health examination is () DA, discover occupational taboo card, distinguish responsibilityB. Master the health status of the laborer, as the basic information of the laborer's health observationC, determine whether the laborer has a professional taboo cardand whether he can do the jobD, above all6. Before any time, the occupational health inspection body shall compile and report the occupational health examination data of this year and report to the local administrative department of health () AA, 10 OctoberB, 10 DecemberC, October 31D, December 31The following is the legal basis for occupational health examination () DA, the law of the People's Republic of China on occupational diseasesB. Measures for the management of occupational health careC. National occupational health standardsD, above allThe purpose of occupational health care is () AA. prevention of occupational diseaseB. Occupational diseaseC. To evaluate the relationship between health changes of workers and occupational-disease-inductive factorsD. Evaluation of occupational hazardNo group or department of the following shall keep the occupational health examination report () CA, employerB. The health administrative department of the employerC. laborersMedical institution10. The employer shall submit the supplementary material () C in the time when it receives the notification of supplementary materialsA, 7 daysB, 10 daysC, 15 daysD, 21 daysNew application of occupational disease diagnosis standard1. After high concentration of high concentration of benzene, which of the following tissues or sites has the highest concentration () CA, the bone marrowB. Adipose tissueC, the brainD, bloodThe main way that mercury invades the body is () AA. respiratory tractB. digestive tractC, skinD, mucous membrane3. The physicochemical properties of phenol are not described correctly (C)A, the deliquescence, slightly soluble in waterB, flammable, explosiveNo smellD, white, translucent acicular crystalsThe total phenol exposure limit is () DA, 155 mg/g creatinineB, 145 mg/g creatinineC, 135 mg/g creatinineD, 125 mg/g creatinine5. The physicochemical properties of benzene are not correctly described () BA, slightly soluble in waterB, not volatileC. Special smellD, soluble in a variety of organic solvents6. Which of the following does not belong to the three typical manifestations of mercury chronic poisoning () BA, elationB, dermatitisC, intentional tremorD. Oral inflammation7. Which organ in the body has the highest mercury content () CA, liverB, spleenC, kidneyD, lung8. Which of the following can be diagnosed as moderately phenolic poisoning () BA, dizzinessB. Moderate toxic nephropathyC, hemolysisD, shockThe main path of phenol excretion is () AA, urineB, excrement and urineC, sweatD, breathe outThe chronic toxicity of benzene is mainly manifested in () BA. central nerve anesthesiaB. Effects of bone marrow hematopoiesisC. Affect the respiratory systemD, affect the digestive systemOccupational health monitoring and evaluation1. Occupational health care content has () DA. contact controlB. Medical contactC. Information managementD, above all2. Which of the following items must be checked () AA, white blood cell count and hemoglobin quantificationBC, neurologyD, urine routine3. Patients with raynaud's disease may not engage in the following related works () CA, noiseB, high temperatureC, vibrationD, dustWhich of the following does not belong to the occupational contraindication () C of lead related worksA. neurological diseasesB. hypertensionC. skin diseaseD, liver and kidney disorders5. The quality of the medical and health institutions that canconduct occupational health examinations shall be approved by the department of health administration () BA, ministry of healthB. Provincial health administration departmentC. Municipal health administration departmentD. County health administration department6. The object of pre-employment health inspection does not include which of the following () AA.B. New video userC. Job changersD. Process changers7. Which of the following items is required to check () DA, dermatologyB, urine routineC, glycosuriaD. X-ray of the bone8. Excessive or functional uterine bleeding may not be related to the following related work () BA, arsenicB, benzeneC, mnD, mercury9. Carriers of hepatitis b can not engage in the following related works () AA, trinitrotolueneB, high temperatureC, the noiseD, vibration10. When calculating the detection rate of chronic diseases (pneumoconiosis), the person who is examined is the length of time () CA, 3 monthsB, 6 monthsC, 1 yearD, 2 yearsTechnical specification for occupational health monitoring (GBZ188 -- 2007)1. The anaemia may not be engaged in the following work () BA, the minersB battery production workshopC, flour millD, geological2. Occupational contraindication of dust industry is () DA, active tuberculosisB. Chronic obstructive pulmonary diseaseC, idiopathic pulmonary fibrosisD, above all3. When contact with coal dust is 15 years, how long should it be followedA, 5 yearsB, 8 yearsC, 10 yearsD, 15 years4. Related to mercury and its inorganic compounds, if the concentration of hazardous substances in the workplace exceeds the national health standard, the health inspection cycle is () BA, 6 months, 1 timeB, 12 monthsC, 18 monthsD, 24 months5. Which of the following situations can be considered as A check () A during departureA, the last health check during the time of duty is 3 months before departureB. The last health check during the job was six months before departureC, the last health check during the period of duty was 8 months before departureD. The last health check during the job was 10 months before departure6. It is incorrect to say (C) that the health inspection statement is incorrectA, the purpose is to find out whether there are any professional taboosB. Establish the basic health records of theoccupational-disease-inductive factorsC. For recommended occupational health examinationsD, should be done before beginning to do harmful homework7. Which of the following does not belong to the occupational contraindication of chlorine gas () DA, copdB. bronchial asthmaC, diffuse pulmonary fibrosisD, porphyrinThe target disease of occupational health monitoring is () AA, occupational disease and occupational taboosB. complicationsC. critically illD. High risk diseaseAfter two years of initial contact, how often should you check () AA, 12 monthsB, 8 monthsC, 6 monthsD, 3 months10. This technical specification has added which of the following occupational health monitoring () BA, video jobB. Prevention and control of liver inflammationC. electrical workD. pressure vessel operationDiagnosis and prevention of lead poisoning1. Which of the following conditions does not transform the phosphate lead stored in the bone into lead phosphate () AA. drink milkB, calcium deficiency,C, drinkingD. Osteoporosis2. Which of the following content of blood lead belongs to the scope of observation () AA, 2.0 mu mol/LB, 3.0 mu mol/LC, 4.0 mu mol/LD, 5.0 mu mol/L3. Which of the following can be classified as severe lead poisoning () BA, mildly toxic peripheral neuropathyB. Toxic encephalopathyC, anemia,D, angina4. The partial reduction of lead in red blood cells is () BA, 24 daysB, 25 daysC, 26 daysD, 27 daysThe absorption of lead is incorrect () BOne tenth of A and pb is absorbed after entering the digestive tractB. In the production environment, the main absorption route is the digestive tractC and tetraethyl lead can be absorbed through the skin and mucosaD. inorganic lead compounds cannot pass through intact skinWhich of the following needs to be removed from lead () CA. mild poisoningB. Moderate poisoningC. Severe poisoningD. Object of observation7. The main passage of lead in the human body is () DA, the salivaB, sweatC, urinateD, excrement and urine8. The treatment of acute lead poisoning in children has (D)。
- 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
- 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
- 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。
What does this percentile mean?2
Normal Prehypertension Stage 1 hypertension Stage 2 hypertension <90th 90-<95th or if >120-80 90>12095th-99th plus 5 mm Hg >99th plus 5 mm Hg
Let’s Practice
AMF is a 5 yo female weighing 25 kg in the 75th percentile of height. Her BP is taken when she goes to the Dr. for a routine visit. Her BP is 114/73. What is her BP percentile? What do we do with this information?
Definitions2
Hypertension: Hypertension: average SBP and/or DBP >95th percentile for gender, age, and height on > 3 occasions Prehypertension: Prehypertension: average SBP or DBP >90th percentile but <the 95th percentile
– Adolescents with BP levels >120/80 mm Hg should be considered prehypertensive
Measurement of Blood Pressure2
Children >3 years old should have their BP measured when seen in a medical setting Preferred method: Auscultation
– Requires a cuff that is appropriate for the child’s arm – Right arm preferred
Blood Pressure Cuff2
Equipment needed to measure BP in children (3-adolescents): (3– Child cuffs of different sizes – Standard adult cuff – Large adult cuff – Thigh cuff
Using the Blood Pressure Tables2
Use the standard height charts to determine the height percentile. Measure and record the child’s SBP and DBP. Use the correct gender table for SBP and DBP. Find the child’s age on the left side of the table. Follow the age row across the table to the intersection of the line for the height percentile. Find the 50th, 90th, 95th, and 99th percentiles for SBP in the left columns and for DBP in the right columns.
StepStep-wise Approach to Therapy2
1. 2.
3. 4.
Start with a small dose of a single antianti-hypertensive drug Increase dose of single antiantihypertensive drug (to max dose if tolerated) Add a small dose of a second drug Increase dose of second antiantihypertensive medication
Possible Etiologies Causing Hypertension2
Chronic Renal Failure Cushing Syndrome Turner Syndrome Hyperthyroidism Systemic Lupus Coarctation of the aorta Wilms tumor
Measurement of BP in children < 3 years old2
History of prematurity, VLBW, or other neonatal complications Congenital heart disease Recurrent UTI, hematuria, or proteinuria Known renal disease or urologic malformations Family history of congenital renal disease SolidSolid-organ transplant Malignancy or bone marrow transplant Treatment with drugs known to raise BP Systemic illnesses associated with hypertension Evidence of elevated ICP (intracranial pressure)
Drug Options for Initial Therapy1
Class of Patients’ Characteristics Drugs ACEACE-Is/ARBs First-line therapy FirstCCBs Diuretics β–Blocker First-line therapy FirstAdjunct second-line drug secondAvoid in athletes (controversial) and people with diabetes
Antihypertensionverting EnzymeEnzymeInhibitors Angiotensin Receptor Blockers Calcium Channel Blockers Diuretics BetaBeta-Blockers Central alpha-agonists alphaPeripheral alpha-antagonist alphaVasodilators
ACEACE-I1-3, 5
Angiotensin Converting Enzyme Inhibitors Benazepril*, Captopril, Enalapril*, Fosinopril*, Lisinopril*, Quinapril
Mechanism of Action: prevents conversion of
angiotensin I to angiotensin II, a potent vasoconstrictor; results in lower levels of angiotensin II which causes an increase in plasma renin activity and a reduction in aldosterone secretion
Treatment Strategies
Therapeutic lifestyle changes Drug therapy
Lifestyle changes
Weight reduction Regular physical activity Restriction of sedentary activity Dietary modification FamilyFamily-based intervention
Treatment of Hypertension in Pediatrics
Kelsey R. Green, Pharm.D. Pediatric Clinical Pharmacist LSULSU-HSC in Shreveport, LA
Objectives
Define hypertension in children Identify when blood pressure should be taken Practice determining BP percentile and interpreting how to use this information to best treat the patient Discuss treatment options used in pediatrics to treat hypertension
Prehypertension
Stage 1 Hypertension
Stage 2 Hypertension
Management Algorithm2
Diagnostic Work-Up6 WorkUrinalysis Protein/Cr Ratio Renal Ultrasound EKG CBC with differential Electrolyetes, BUN, Cr Rule out infection, hematuria, proteinuria Kidney function Rule out renal scarring, congenital renal anomalies Cardiomegaly Rule out anemia, consistent with chronic renal disease Rule out renal disease, pyelonephritis